Clinical characteristics and treatment utilization by tumor subtype among metastatic breast cancer patients in a large US managed care health plan

被引：0
作者：
Burton, Tanya [1 ]
Byfield, Stacey DaCosta [1 ]
Fan, Ying [1 ]
Fang, Yiyu [1 ]
Cao, Feng [1 ]
Smith, Gregory L. [2 ]
Zanotti, Giovanni [2 ]
Bell, Timothy J. [2 ]
Perkins, Julia J. [2 ]
Horblyuk, Ruslan [2 ]
Teitlebaum, April
机构：
[1] Optum, New York, NY USA
[2] Pfizer, New York, NY USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P3-07-24
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-07-24
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Patterns of utilization of imaging and tumor markers (TM) among metastatic breast cancer (MBC) patients (pts).
    Di Meglio, Antonio
    Lin, Nancy U.
    Freedman, Rachel A.
    Barry, William Thomas
    Winer, Eric P.
    Luis, Ines Vaz
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Palliative care and healthcare utilization among metastatic breast cancer patients in U.S. Hospitals
    Sun Jung Kim
    Isha Patel
    Chanhyun Park
    Dong Yeong Shin
    Jongwha Chang
    Scientific Reports, 13
  • [33] The contribution of clinical subtype to survival differences among patients with de novo and recurrent metastatic breast cancer (dMBC).
    File, Danielle Marie
    Pascual, Tomas
    Deal, Allison Mary
    Wheless, Amy
    Dees, Elizabeth Claire
    Carey, Lisa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Clinical characteristics of patients with metastatic breast cancer with complete remission following systemic treatment
    Yamamoto, N
    Katsumata, N
    Watanabe, T
    Omuro, Y
    Ando, M
    Narabayashi, M
    Adachi, I
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (06) : 368 - 373
  • [35] Tumor phenotype and characteristics of metastatic brain involvement in breast cancer patients: Potential clinical consequences
    Palacova, M.
    Svoboda, M.
    Fabian, P.
    Ondrova, B.
    Grell, P.
    Jana, G.
    Princ, D.
    Radova, L.
    Slampa, P.
    Vyzula, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS NEWLY TREATED FOR PULMONARY ARTERIAL HYPERTENSION IN A REAL-WORLD DATABASE REPRESENTING A LARGE US HEALTH PLAN
    Hull, M.
    Pruett, J.
    Elliott, C.
    Tsang, Y.
    Drake, W.
    VALUE IN HEALTH, 2019, 22 : S119 - S119
  • [37] TUMOR NECROSIS FACTOR-BLOCKER USE IN US MANAGED CARE: UTILIZATION AND DOSING PATTERNS AMONG RHEUMATOID ARTHRITIS PATIENTS
    Fisher, M.
    Watson, C.
    Fox, K. M.
    Chen, Y. -W.
    Gandra, S. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 520 - 520
  • [38] PIK3CA testing and treatment patterns among patients with metastatic breast cancer in US community clinical practice
    Kim, Eunice
    Dhillon, Preet Kaur
    Lambert, Peter
    Cheng, Anna
    Basho, Reva K.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Survivorship Care Plan Preferences and Utilization Among Asian American Breast Cancer Survivors
    Nolan, Timiya S.
    Arthur, Elizabeth
    Nwodim, Ogechi
    Spaulding, Amelia
    Kue, Jennifer
    ONCOLOGY NURSING FORUM, 2021, 48 (05) : 507 - 521
  • [40] Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis
    Peter P Toth
    Victoria Zarotsky
    Jane M Sullivan
    Dave Laitinen
    Cardiovascular Diabetology, 8
12345